Cefoperazone in Klebsiella meningitis: a case report
Related Experiment Video
Updated: Nov 3, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Abstract:
A 51-year-old man with meningitis due to Klebsiella pneumoniae was treated with cefoperazone 6 to 8 g/day intravenously and was cured. Simultaneous blood and cerebrospinal fluid levels were measured. Trough levels of cefoperazone in cerebrospinal fluid were 9 and 12 mg/L. Cefoperazone should be considered for meningitis due to susceptible organisms resistant to customarily used antibacterial drugs.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Rocky Mountain Spotted Fever
Bacterial Meningitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology